Cytokinetics Inc (CYTK) Live Stock Price, Forecast & News | FX Empire

Advertisement

Advertisement

Cytokinetics Inc
CYTK
(Nasdaq - US)
Closed
51.00
-0.31 (-0.60%)
in:usd•As of: Oct 31, 2024 15:59 UTC -4
After Market:50.8-0.20 (-0.39%)
Open
50.95
High
51.21
Low
50.55

Stats

Prev. Close

51.31

Open

50.95

Day's Range

50.55 - 51.21

52 Week Range

30.68 - 110.25

YTD Change

-38.91%

1 Year Change

58.93%

Market Cap

6.00B

P/E Ratio

N/A

Volume

30,362

Beta

0.77

Sector

Health Technology

Industry

Pharmaceuticals Major

Economic CalendarAll Events

Time zone: GMT

Thursday, October 31st 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
12:30	USD	Personal Spending MoMSep	High	0.5%	0.4%	0.3%
12:30	USD	Core PCE Price Index MoMSep	High	0.3%	0.3%	0.2%
12:30	USD	Personal Income MoMSep	High	0.3%	0.3%	0.2%
13:45	USD	Chicago PMIOct	Medium	41.6	47	46.6

Friday, November 1st 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
12:30	USD	Participation RateOct	Medium		62.5%	62.7%
12:30	USD	Average Hourly Earnings YoY	Medium		4%	4%
12:30	USD	Average Hourly Earnings MoMOct	Medium		0.3%	0.4%

Latest News

featured

BenzingaSep 9, 2024

Cytokinetics Sets Stage For Mid-Stage Study For Heart Failure Drug After Encouraging Data From Phase 1 Study

CYTK-0.60%

featured

Seeking AlphaAug 13, 2024

Cytokinetics: Aficamten Rolling NDA Submission Leads To Expansion Opportunities

CYTK-0.60%

featured

Seeking AlphaAug 10, 2024

Cytokinetics, Incorporated (CYTK) Q2 2024 Earnings Call Transcript

CYTK-0.60%

featured

Zacks Investment ResearchAug 9, 2024

Cytokinetics (CYTK) Q2 Loss Wider Than Expected, Pipeline in Focus

CYTK-0.60%

featured

Zacks Investment ResearchAug 8, 2024

Cytokinetics (CYTK) Reports Q2 Loss, Lags Revenue Estimates

CYTK-0.60%

featured

Zacks Investment ResearchJul 25, 2024

Cytokinetics (CYTK) Expected to Beat Earnings Estimates: Should You Buy?

CYTK-0.60%

Data Vendor: Xignite Logo

Stocks

Loading

Loading

Trade With A Regulated Broker